Neuropsychopharmacology
- Assisting schizophrenia diagnosis using clinical electroencephalography and interpretable graph neural networks: a real-world and cross-site study2 years ago
- The orexin neurotransmitter system as a target for medication development for opioid use disorder2 years ago
- Functional connectivity of salience and affective networks among remitted depressed patients predicts episode recurrence2 years ago
- Correction to: Pathways link environmental and genetic factors with structural brain networks and psychopathology in youth2 years ago
- Puerarin attenuates valproate-induced features of ASD in male mice via regulating Slc7a11-dependent ferroptosis2 years ago
- Bayesian dynamical system analysis of the effects of methylphenidate in children with attention-deficit/hyperactivity disorder: a randomized trial2 years ago
- Disassociating drug active ingredients from inactive: ketamine-like synaptic effects of a ketamine excipient2 years ago
Journal of Psychopharmacology
- Selective attention to emotional stimuli and emotion recognition in patients with major depression: The role of mineralocorticoid and glutamatergic NMDA receptors4 years ago
- Discontinuation and relapse with paliperidone palmitate three-monthly for maintenance of schizophrenia: Two year follow-up of use in clinical practice4 years ago
- Easier patient access to medical cannabis carries risks as well as benefits4 years ago
- Hydrocortisone as an adjunct to brief cognitive-behavioural therapy for specific fear: Endocrine and cognitive biomarkers as predictors of symptom improvement4 years ago
- Preliminary evidence for the phosphodiesterase type-4 inhibitor, roflumilast, in ameliorating cognitive flexibility deficits in patients with schizophrenia4 years ago
- Why should pharmacological trials in schizophrenia employ functional magnetic resonance imaging (fMRI)?4 years ago
- Antidepressant action of transcranial direct current stimulation in olfactory bulbectomised adolescent rats4 years ago
European Neuropsychopharmacology
- A review and meta-analysis of gene expression profiles in suicide4 years ago
- Exploring the relationship between the gut microbiome and mental health outcomes in a posttraumatic stress disorder cohort relative to trauma-exposed controls4 years ago
- COVID-19 and Behavioral Addictions: Worrying consequences?4 years ago
- Null effect of vortioxetine augmentation with celecoxib should not be generalized to other antidepressants – Author’s reply4 years ago
- Selective association of cytokine levels and kynurenine/tryptophan ratio with alterations in white matter microstructure in bipolar but not in unipolar depression4 years ago
- A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response4 years ago
- Emotional cognition in depression: Is it relevant for Clinical practice?4 years ago